The subsequent medical review was intended to prevent implantation of a patient with near-term expectations of a required MRI. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic. In contrast to other currently available systems that use frequencies in the range. Class action. Optimizes and maintains. When choosing a physician, we encourage you to complete your own research, as Nevro does not verify or monitor the qualifications. Minimal restrictions and reversible. Company Announces Preliminary, Unaudited Second Quarter 2021 Revenue of Approximately $102. Nevro (NYSE:NVRO) said yesterday that the FDA approved MRI-conditional labeling for its Senza spinal cord stimulation system designed to deliver HF10 therapy. This article reviews Nevro Corporation's (CA, USA) Senza System high-frequency spinal cord stimulator (HF10 SCS). Jump to this post . This is the full video interview with one of our patients who had life-changing success with the Nevro HF10 Spinal Cord Stimulator. Jude Prodigy, 17 for the Medtronic (Minneapolis, MN) Restore, 1 for the. *Meantime from implant to last visit is nine months. By. Address: Prielmayerstraße 3, 80335 München. Preguntas frecuentes sobre el HFX. Mayfield presents a patient symposium on a new type of spinal cord stimulation, called high-frequency HF10 Therapy, that delivers 10,000 Hz to provide more p. 0%) than traditional SCS (46. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT), the largest RCT to evaluate spinal cord stimulation. We’re here to help you. Visit Website. HF10 therapy remains a preferred way of using electricity to treat chronic pain, as this therapy doesn’t produce a feeling of. The table below contains the HCPCS Level II codes, as well as the L-codes that might be listed in a medical policy or commercial contract. CONCLUSION: This study demonstrates long-term superiority of HF10 therapy com-pared with traditional SCS in treating both back and leg pain. (650) 251-0005. A major clinical study found that nearly 80% of people experienced significant pain relief with HFX compared to only 49% of people with a traditional spinal cord stimulator 6. . Summary. HFX logo. REDWOOD CITY, Calif. and international patents. Spinal cord stimulation (SCS) delivered at 10 kHz (as in HF10 therapy) may provide pain relief without the paresthesias typical of. Expanding Patient and Surgeon Access to Nevro's HF10™ Therapy, Labeled Superior to Traditional SCS Therapy for Chronic Back and Leg Pain Nevro Corp. Nevro's SENZA-PDN study, the largest randomized clinical trial (RCT) of spinal cord stimulation treatment conducted thus far, compares HF10 therapy plus Conventional Medical Management (CMM) to. While we wait for others to join in, here's a list of related discussions on Connect that you may wish to review and ask questions to specific members. Website (855) 637-2987. The forecasts range from a low of $33. (NYSE:. 2 years. "It's given me back my life" – Rod SEE MORE PATIENT REVIEWS Getting started is easy 1 Do you qualify? Answer a few questions to find out if you’re a candidate. Adam Young received a stimulator to treat back pain caused by two prolapsed discs in his spine. Hi all! I’ve got CRPS type II (formerly known as RSD) caused from multiple, ongoing procedures to treat a large AVM in my left leg. The Senza spinal cord stimulation (SCS) system (Nevro) is a neuromodulation device that delivers electrical impulses to the spinal cord. , Redwood City, CA, USA) or traditional SCS commercially available,. Subscribe & Save. I have dealt with chronic nerve pain (neuropathy and radiculopathy) ever since. Wisconsin. 33 to a high of $78. Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the. e. S. Jude Proclaim, 32 for the St. The HFX App was developed by Nevro to work with the HFX iQ™ Spinal Cord Stimulator. This approval is specific to Nevro's unique 10 kHz stimulation, and Nevro now has the only spinal cord stimulation system approved by the FDA with a specific indication to treat PDN. The system is programmed to provide most waveforms in a single product, solely or when paired with HF10. HF10 is able to be implanted through a minimally invasive outpatient procedure that allows patients to go home the same day. Reduce cravings and stress eating with this delicious chai herbal supplement, Stave the Crave. This can provide long-term relief from limb pain while still allowing patients. In case you are still confused, do not worry!Implanting HFX requires only 2 small incisions and is performed with anesthesia or sedation to make it comfortable for you. AbstractBackground:. S. I have complete confidence in this unit because the temporary one that they inserted worked unbelievably well. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the. Dr Subbaroyan has a patent for painful diabetic neuropathy and sensory modulation pending to Nevro Corp and owns stocks in Nevro Corp. Spinal cord stimulation was approved by the U. This has been getting very frustrating. Nevro Medical Limited (acting through Nevro Germany GmbH) Email: nevro@iitr. The X in HFX signifies that our solution now is more than 10 kHz high-frequency stimulation. Unlike other spinal cord stimulators, HF10 does not cause tingling, or paresthesia, and can be used while. The safety of the Senza system for cervical MRI was not established at the time of study initiation. Access to the clinical evidence portfolio supporting our therapy. In 2018, Gill et al. One thing I do know with your problem is. Provide full outsource solutions to individual. Manuals and User Guides for Nevro HF10. HFX™ for PDN Now the Only Spinal Cord Stimulation System Approved by FDA to Treat PDN¹ Company Will Immediately Initiate Commercial Launch Activities in the U. Nevro HFX Care Team Support. No neuropathy thankfully. 9 out of 10 people choose to keep it. I would say I was sleeping "uncomfortably" for about 3-4 days. 1 like · 8 were here. I had Stimwave spinal stimulator placed a year ago and nothing but problems and severe pain thinking of having it removed and possibly replaced with nevro hf10 . When choosing a physician, we encourage you to complete your own research, as Nevro does not verify or monitor the qualifications of any physicians in this database. Unlike non-rechargeable systems, the Omnia system is designed to last over ten years and has. The therapy is called spinal. 1 Kapural L. Anesthesiology, 123(4); 2. I'm writing from across the pond. , et al. Quick, outpatient & minimally invasive. SENZA OMNIA, OMNIA, SURPASS, SURPASS-C, HF10, the HF10 logo, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX. HF10 is delivered by the Senza Spinal Cord Stimulation system. Mr Gliner has a patent for HF10 therapy and related issued to Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic. com. HFX is placed in your lower back or buttocks area (your doctor will help decide which location is right for you). 19,599 likes · 700 talking about this. Im in more pain now then I was before surgery. Which is the best Spinal Stimulator. The company has great employee retention with staff members usually staying for 3. Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. RESULTS In the per protocol population, the primary endpoint (≥50% pain relief at 3 mo) was achieved in 86. Posted by elsa @elsa, Jul 26, 2020. more is better. I have been suffering chronic foot and left thigh, calf burning pain ever since. Un Tratamiento Innovador Para el Dolor Crónico. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the. The trial went okay. 0% 6 40. hospitals are more likely to have the type of MRI machine that is compatible. Others will feel a gradual increase in pain in the weeks following their surgery. Easily pair the widest array of waveform types, including paresthesia-based. Nov. The risk of using other types of RF coils has not been evaluated. . Data on file. I am scheduled to have the Nevro Hf10 spinal stimulator put in at the end of August. SOURCE Nevro Corp. I have had 8 back surgeries over the last 3 1/2 years, the last ones January 2018 which L1-L5 was fused. NEVRO CORP. The most recent systematic and comprehensive review of the effectiveness of SCS in treating chronic spinal. Considering getting removed. "We are pleased that the resolution of this matter recognizes the innovation behind HF10® therapy, and the strength of the intellectual property that protects it," said Kashif Rashid, General Counsel, Nevro. HF10 is able to be implanted through a minimally invasive outpatient procedure that allows patients to go home the same day. Furthermore, the number of patients using opioids dropped from 90% to 12%. The four biggest makers of spinal-cord stimulators are Boston Scientific Corp. Overview; How HFX Works; What to Expect;. 30-day supply. The treatment Senza provides (known as HF10 therapy) is a combination of high-frequency (10 kHz) low-amplitude electrical pulses designed to relieve pain and not be felt by the patient, and a. HF10 therapy has been shown to be. S. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT), the largest RCT to evaluate spinal cord stimulation. "This submission is a significant milestone in the evaluation of Nevro's proprietary HF10 high frequency spinal cord stimulation therapy to address the many. they will call NEVRO and get the specs doe the MRI machine. Additionally, Nevro's system does require daily recharging, but it is only for 30 minutes a day. 9×1. High frequency technology also requires no paresthesia, rendering the sensor device completely obsolete. At each stage of development, our research was subject to. Looking for info on anyone who has had stimulator leads removed and replaced with another stimulator. Tried Medtronic trial did not work. All walking and standing causes intense nerve pain in my. HF10 therapy uses high-frequency pulses that actually block the pain. if you run into any issues just call texhnical support at NEVRO. MENLO PARK, Calif. Message * Required. NVRO, a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. The Nevro HF10 is a type of Spinal Cord Stimulation (SCS) and is named for its ability to deliver high-frequency stimulation at 10 kHz. they will call NEVRO and get the specs doe the MRI machine. Results: Twenty-three of 24 subjects (95. Why HFX TM. The latest negative side effects reported from spinal cord simulators are: Increased pain: An increase in pain is one of the most common negative side effects reported. HFX includes the widest range of frequencies and waveforms available, uniquely offering you 10 kHz high-frequency and low-frequency programs. It is a revolutionary evidence-based therapy that has already been shown to provide pain relief for various patients. Programming options: HFX offers the most frequencies and waveforms available. This article provides an overview of HF10 and highlights Nevro’s new Omnia™ implantable pulse generator (IPG) (Nevro Corp. 1800 Bridge Parkway Redwood City, CA 94065. Nevro Senza® Omnia™ is the first and only spinal cord stimulation (SCS) system designed to deliver all SCS frequencies between 2 and 10,000 Hz. The HF10™ therapy has been quite successful in treating pain relief and offers a long-term solution for patients suffering chronic back and leg pain. Unfortunately, these medications have many potential side effects and risks. With Nevro 1 HF10; Repetition time 3,692 2,903; Time to echo 120 120; Number of excitations 2 1; Bandwidth 154 367. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain. For more than a decade, HF10 has. The system delivers SCS frequencies between 2Hz and 10,000Hz, along with the company’s HF10 therapy, which combines a 10kHz frequency. 19, 2021 /PRNewswire/ -- Nevro Corp. Recent and relevant conference proceedings known to the authors were also included in the review. “It’s just a big waste of time, and an absolute. Your spinal cord stimulator recovery period after the implant procedure will be a little longer than your trial recovery. HF10 therapy is a non-opioid, reversible therapy that may represent a compellingExpanding Patient and Surgeon Access to Nevro's HF10™ Therapy, Labeled Superior to Traditional SCS Therapy for Chronic Back and Leg Pain Nevro Corp. To learn more about HF10 Spinal Cord Stimulation, call the Pain Arthritis Relief Center today to schedule a consultation with a specialist. Throughout this website all referenced devices including the Implant, Leads, and Patient Accessories are a part. The Dr wants to do additional surgery. SENZA II, SENZA OMNIA, OMNIA, SURPASS, SURPASS-C, HF10, the HF10 logo, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access. A multicenter Real-world review of 10kHz SCS outcomes for treatment of chronic trunk and/or limb pain. HFX is a small device that safely delivers pain relief by sending gentle pulses. • Use only a transmit/receive RF head coil or transmit/receive RF local coil. HFX isn’t addictive and doesn’t cloud your thoughts, cause drowsiness. In case you are still confused, do not worry! Implanting HFX requires only 2 small incisions and is performed with anesthesia or sedation to make it comfortable for you. Choose or Blend Mechanisms of Action. is relying on compelling clinical data to drive adoption of its Senza line of spinal cord stimulation systems delivering its proprietary HFX (high-frequency) 10 kHz spinal cord stimulation therapy. 3876 Nevro. That program helped immensely and I got off 5 meds. my lower legs. An SCS system capable of delivering stimulation frequencies up to 10 kHz has been developed (Senza® SCS system, Nevro Corp, Menlo Park, CA, USA). Now Available, FDA-Approved, Artificial Intelligence-based HFX iQ™. Important safety, side effects, and risks information. my Nevro was installed in July, 2017, On the advice from my neurosurgery Doctor, he referred me to a pain specialist an he installed the Nevro H10. 67. Courtesy of Nevro Corp + Boston Scientific Corporation. The safety of HFX has been thoroughly studied and proven. What is Nevro HFX? HFX is a nondrug, FDA-approved treatment option for long-term chronic pain relief. My pain management doctor has recommended it to me for. ” On a form filed with the SEC on February 22, 2018, Nevro also stated in relevant part: “We are extending our novel and proprietary technologies into a series of product enhancements with the goal of improving the treatment of chronic pain. you may need to have the battery adjusted, and you may need to replace it, That's all I know. Product Manuals. Learning each patient’s preferences and pain experience to personalize therapy recommendations 2. 9415 info@nevro. The litigation. Spinal cord stimulation is proven to be very successful for many people who have tried other treatment options like pain medications, surgery, and injections. NEVRO CORP. A Multicenter Real-World Review of 10kHz SCS. Petersen, E, et. “It’s just a big waste of time, and an absolute. Nevro’s unique PDN indication is the outgrowth of years of investments in clinical trials culminating with the SENZA-PDN, the largest RCT evaluating SCS for PDN to date. REDWOOD CITY, Calif. The goal of this review is to examine the evidence and outcomes related to spinal cord stimulation for painful diabetic peripheral neuropathy in order to further evaluate the safety and efficacy of these procedures. Nevro Corp. 251. 001 for non-inferiority and P =. Consultation and sales of outsourced surgical equipment to operating rooms and physician's clinics. . Data sources included relevant literature identified through searches of. The company is the creator of HFX TM, one comprehensive solution for individualized relief of chronic pain. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain. Full Body MRI7 All Nevro systems are conditionally approved for full body MRI scans. This booklet presentsHF10 Therapy Labeled as Superior to Traditional SCS Therapy for Chronic Back and Leg Pain Conference Call on Monday, May 11 at 8:30 a. a different manufacturer attached to the Nevro IPG. The ability to pair. In addition to Nevro's proprietary HF10 waveform, Omnia offers the most waveforms on one device and can be programmed to provide waveforms independently or paired with HF10. 5 months later revealed the cage migrated out of the surgical spot and now is again causing stenosis. Petersen, E, et. The Senza SCS. I didn't have this pain prior to surgery. Review the MRI guidelines with the doctor who implanted your spinal cord stimulator;. Minimal restrictions and reversible. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has. It is FDA-approved for driving and is covered by Medicare and most private insurers. 7% (n = 39/45) subjects. ¹. Address: Carrick House, Lypiatt Road, Cheltenham, Gloucestershire, GL50 2QJ. , Nevro develops products for patients suffering from debilitating chronic pain. launch activities to provide HF10® therapy for the treatment of chronic pain in PDN patients. -the Nevro high frequency device works completely differently do some of the others. Nevro routinely posts information that may. This system delivers electrical. Posted 5 years ago, 18 users are following. Average of 6 Customer Reviews. METHODS: A pragmatic randomized,. Patients;. Senza, Senza II, Senza Omnia, HF10, Nevro and. , Jan. Company size. An SCS system capable of delivering stimulation frequencies up to 10 kHz has been developed (Senza® SCS system, Nevro Corp, Menlo Park, CA, USA). S. For some folks with the HF10. Important Safety Information. 16×3;. Historias de pacientes reales. Anesthesiology, 123(4) 2 Kapural L. My name is Glen and i have had the Nevro HF10 spinal stimulator implanted since Sept 1, 2021 and the company rep hasn't been able to dial it in on my terrible lower back pain yet. This has been getting very frustrating. 0005 Fax: +1. 1 Kapural L. Adam Young received a stimulator to treat back pain caused by two prolapsed discs in his spine. al. HF10 does not use over-the-counter or prescription medication, including opioids. 1% 6 36. Given the prevalence and burden of intractable pain, additional therapeutic approaches are desired. and international patents. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain. Manfield - 553362 86. It sounds like you are not having a problem with the device itself (I don't see any class actions against the company at this time but if you are having trouble with the device, a Personal Injury lawsuit is always a possibility). Learn how HFX works, how to get it, and what to expect. Remote Control ON/OFF Button 2. 5’ x 15. The main solution offered by Nevro is the infamous HF10™ therapy, which is a neuromodulation platform used for treating chronic pain. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain. While we wait for others to join in, here's a list of related discussions on Connect that you may wish to review and ask. Nevro HFX Chronic Pain Relief. JAMA Neurology, April 2021. Nevro, an innovative new medical device company, has developed a disruptive technology with HF10 Therapy. HF10 does not use over-the-counter or prescription medication, including opioids. The system is programmed to provide most waveforms in a single product, solely or when paired with HF10. Nevro Announces First Commercial Procedure of HF10™ Therapy in the United States. I had the initial implant put in around 2004. HF10 therapy. Nevro's SENZA-PDN study, the largest randomized clinical trial (RCT) of spinal cord stimulation treatment conducted thus far, compares HF10 therapy plus Conventional Medical Management (CMM) to. HF10 therapy has the strongest prospective published clinical evidence demonstrating a reduction in opioids Changes in Pain Care Continuum Potential for SCS to move up care continuum as a less invasive option for non surgical patients with increased evidenceHFX iQ™ personalizes each patient’s pain relief journey by: 1. Popular Searches nevro Corp Nevro Nevo Corp Evro Corporation Inc HF10 therapies SIC Code 38,382 NAICS Code 42,423 Ticker NYSE:. These people are all volunteers who share their personal experiences with HF10. Nevro is a medical device company and creator of HF10. S. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received approval from the U. But to me, it seems you may need, if you haven't had it already, is to have it adjusted and programmed again. 251. Read testimonials from people who have found relief from low. Nevro is a medical device company and creator of HF10®, an innovative, evidence-based treatment for chronic pain. The Nevro HF10 is a type of Spinal Cord Stimulation (SCS) and is named for its ability to deliver high-frequency stimulation at 10 kHz. Hi patricia . Introducción al estimulación de la médula espinal. This submission, assuming a six-month review cycle and regulatory approval from the FDA, would position the company to achieve approval and initiate U. Nevro is a medical device company headquartered in Redwood City, California. I talked to my dr and a Nervo HF10 rep today. The web page reviews the advantages and disadvantages of spinal cord stimulation, including the novel 10-kHz high-frequency therapy (HF10) that has better results than traditional low-frequency therapy. 0005The Senza ® System, Senza II™ System, and the Senza ® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10 ® therapy. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received approval from the U. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has now initiated the. The US Food and Drug Administration has approved the next-generation Senza II Spinal Cord Stimulation (SCS) System (Nevro) delivering HF10 therapy. Now Available, FDA-Approved, Artificial Intelligence-based HFX iQ™. Senza HFX iQ is the first and only Artificial Intelligence-based SCS system that learns. S. HF10 therapy has been shown to be noninferior to. Compared to traditional spinal cord stimulation, where only 49% of people with back and leg. The four biggest makers of stimulators are Boston Scientific Corp. Nevro Corp. -based. Nevro and the specialist have been notably quieter since it was clear the implant was not a 'very' successful one, but they are still supportive. Every person is unique and your medical needs differ from those of others, even people with the same condition and the same SCS system. Battery Level Indicator (Charge Level of. Nevro’s HF10® therapy is an innovative method of treating pain, which provides a possible solution which could restore both your independence and enjoyment in life. 7% battery failure rate, but nearly 69% of those occurred after three years, which may be indicative of battery life versus true failure rate. All questions or concerns about Nevro Corp. 888. About Nevro Headquartered in Redwood City, California , Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients. Licensed for 23 years. NEVRO CORP. It can be effective for some people with chronic back and leg pain, but it has device-related complications, serious injuries, and limitations. 2. Nevro Corp. 2. After a trial period of about a week, if the patient is achieving good results the device is implanted in the person. Novel 10-kHz High-frequency Therapy Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain. This system delivers electrical stimulation pulses at high frequency (10,000 Hz) as compared with traditional low-frequency SCS systems (typically around 50 Hz. 0 cm at 36 months. All you have to do is tell the place where you are having your MRI (preferrably a hospital) that you have a NEVRO HF10. Calculated from patient survey data and functionality measures within the SENZA-RCT. With respect to CRPS, I would be wary that the implant has less proven effectiveness than with actual spinal issues - my personal belief is that the CRPS my wife has may be neurological but NOT spinal. Clinical evidence and patient outcomes: HFX is clinically proven to help people achieve more pain relief. Complete the form below so a Nevro HFX Care Team Member can contact you to answer your questions and help you find an HFX-trained doctor. A discussion forum where users share their experiences and opinions about the HF10 device, a device that stimulates the spinal cord to help relieve back and leg pain. Outcomes. Additionally, Nevro's system does require daily recharging, but it is only for 30 minutes a day. 1800 Bridge Pkwy. , May 22, 2015 /PRNewswire/ -- Nevro Corp. Less well understood are the adverse neurological effects of this therapy. Follow. The Redwood City, Calif. According to the company, the Senza II system offers the superior outcomes and clinical advantages of HF10 therapy through a smaller and more refined footprint while. roradiologist and/or surgeon were also present to review the im-. Upgradable to future waveforms and frequencies. Revenue. In total, 142 patients implanted with Nevro's high-frequency (10 kHz) SCS system, Nevro HFX, were followed for 24 months, including 84 initial 10 kHz SCS+CMM recipients and 58. Database includes US Physicians only. , Menlo Park, USA) in patients suffering from neuropathic, chronic neck, and upper limb pain refractory to conservative and surgical treatment. You wear a device under your clothes or on a belt that delivers stimulations to the leads. Food and Drug Administration in 1984. The system is capable of delivering the HF10. 0005 Fax: +1. Quick, outpatient & minimally invasive. Been in Dr's office with Nevro Rep several times to re- adjust level and frequency. This application allows patients to input their daily pain, medication use and activity levels to provide a personalized therapy. Australia: +61 488 845 285. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. Jameson, J, Johnson, C et al. , Jan. In a clinical study, nearly 80% of people experienced at least 50% pain relief with HFX compared to only 49% of people with a traditional spinal cord stimulator 7.